Immutep Limited (ASX:IMM)
0.2500
-0.0100 (-3.85%)
Sep 16, 2025, 4:10 PM AEST
Immutep Market Cap
Immutep has a market cap or net worth of 366.97 million as of September 16, 2025. Its market cap has decreased by -35.22% in one year.
Market Cap
366.97M
Enterprise Value
238.90M
Revenue
5.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 366.97M, an increase of 9,918.29%. That is a compound annual growth rate of 17.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 16, 2025 | 366.97M | -30.93% |
Dec 31, 2024 | 531.29M | 29.54% |
Dec 29, 2023 | 410.15M | 69.62% |
Dec 30, 2022 | 241.81M | -42.22% |
Dec 31, 2021 | 418.52M | 55.46% |
Dec 31, 2020 | 269.22M | 166.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 99.05B |
Pro Medicus | 30.74B |
Cochlear | 19.80B |
Sonic Healthcare | 11.13B |
Ramsay Health Care | 7.76B |
Ansell | 4.89B |
Telix Pharmaceuticals | 4.74B |
Mesoblast | 2.97B |